<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Stefanwill - Latest News</title>
<link href="https://news.prfree.org/rss/stefanwill/latest.xml"></link>
<updated>2026-07-21T21:43:00+00:00</updated>
<id>urn:uuid:9b3da3ca-90db-a4f1-6c9d-17277fa4a8ec</id>
<entry>
<title>The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030, predicts Roots Analysis</title>
<link href="https://news.prfree.org/@stefanwill/the-contract-manufacturing-market-for-pharmaceuticals-in-china-is-estimated-to-be-worth-usd-13-billion-in-2030-predicts-roots-analysis-n6maa68nrmad"></link>
<id>urn:uuid:b8979897-bdb1-9d3d-6405-568601b53083</id>
<summary type="html"><![CDATA[Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world]]></summary>
<updated>2021-10-12T07:54:47+00:00</updated>
</entry>
<entry>
<title>The Companion Diagnostics Development Services Market</title>
<link href="https://news.prfree.org/@stefanwill/the-companion-diagnostics-development-services-market-eqmjea5xwkr6"></link>
<id>urn:uuid:abddde05-e06b-7ecb-5dc6-e8374fdbcb80</id>
<summary type="html"><![CDATA[In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise]]></summary>
<updated>2021-10-12T07:51:15+00:00</updated>
</entry>
<entry>
<title>The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis</title>
<link href="https://news.prfree.org/@stefanwill/the-blood-brain-barrier-bbb-penetrating-drugs-market-is-estimated-to-be-worth-usd-900-million-in-2030-predicts-roots-analysis-6rm5rnbxjkw4"></link>
<id>urn:uuid:9ec4ce94-5a91-a0f7-38dc-86a85e47cfec</id>
<summary type="html"><![CDATA[Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models.]]></summary>
<updated>2021-10-11T09:43:05+00:00</updated>
</entry>
<entry>
<title>The nuclear medicine and radiopharmaceutical manufacturing market is estimated to be more than USD 6 billion in 2030, predicts Roots Analysis</title>
<link href="https://news.prfree.org/@stefanwill/the-nuclear-medicine-and-radiopharmaceutical-manufacturing-market-is-estimated-to-be-more-than-usd-6-billion-in-2030-predicts-roots-analysis-p7ke84enbmwx"></link>
<id>urn:uuid:e53fa829-1123-933a-3a45-55e1f1d98b20</id>
<summary type="html"><![CDATA[Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models.]]></summary>
<updated>2021-10-11T09:40:07+00:00</updated>
</entry>
</feed>